2014 annual financial data

Rigel Pharmaceuticals, Inc. 2014 Operating margin

Rigel Pharmaceuticals, Inc. 2014 operating margin with verified reported values.

Direct answer

Operating margin was -1,106.05%.

Operating income was -91,249,000 USD and net income was -90,908,000 USD.
Operating cash flow was -69,753,000 USD.

Get free Rigel Pharmaceuticals, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
8,250,000 USD
Operating income
-91,249,000 USD
Net income
-90,908,000 USD
Operating cash flow
-69,753,000 USD